Long Island is at the forefront of a pressing environmental and public health crisis, grappling with pervasive contamination of its drinking water by per- and polyfluoroalkyl substances (PFAS), widely known as “forever chemicals.” This challenge is intensified by ongoing regulatory battles at the federal level, with a contentious debate surrounding the enforcement and timelines for addressing these harmful contaminants.

In April 2024, the Biden administration's Environmental Protection Agency (EPA) finalized strict limits on six specific PFAS compounds in drinking water, with water suppliers mandated to achieve compliance by 2029. However, the current EPA, under Administrator Lee Zeldin, has indicated a potential shift in policy. Notably, a deadline for water utilities to comply with new federal standards for unregulated short-chain PFAS has been delayed by two years, to 2031, extending a deadline initially set by the previous administration. Representative Tom Suozzi (D-Glen Cove) has vehemently urged Zeldin to recall his past advocacy for Long Islanders and reverse course, emphasizing their shared legislative history on aggressive measures against these chemicals and the profound impact on the region’s sole-source aquifer.

The health implications of PFAS exposure are a critical concern, with scientific studies, including those from the National Institutes of Health, consistently linking these chemicals to a higher incidence of various cancers, particularly kidney, breast, and testicular cancer. Other associated health problems include reduced immunity, thyroid disorders, and developmental delays in children. The EPA itself has stated that “there is no level of exposure to these contaminants without risk of health impacts.” Long Island, in particular, has long been noted for its elevated breast cancer rates, underscoring the urgency of effective protections.

Adding to the complexity are the lesser-understood